Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3812-3819

  Glant, Tibor T ^a   Buzás, Edit I ^c   Finnegan, Alison ^a,b   Negroiu, Gabriela ^a   Cs Szabó, Gabriella ^a   Mikecz, Katalin ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CROSS REACTING ANTIGEN; GLYCOSAMINOGLYCAN; KERATAN SULFATE; PROTEOCHONDROITIN SULFATE; T LYMPHOCYTE ANTIGEN;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CARTILAGE; CONTROLLED STUDY; CROSS REACTION; FETUS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGGRECANS; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ARTHRITIS; CARBOHYDRATE SEQUENCE; CARTILAGE, ARTICULAR; CATTLE; CROSS REACTIONS; EPITOPES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; GLYCOSAMINOGLYCANS; HUMANS; LECTINS, C-TYPE; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEOGLYCANS;

EID: 0032522487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Glant, T. T., K. Mikecz, A. Arzoumanian, and A. R. Poole. 1987. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum. 30:201.
2. Mikecz, K., T. T. Glant, and A. R. Poole. 1987. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 30: 306.
3. Glant, T. T., K. Mikecz, E. J. M. A. Thonar, and K. E. Kuettner. 1992. Immune responses to cartilage proteoglycans in inflammatory animal models and human diseases. In Cartilage Degradation: Basic and Clinical Aspects. J. F. Woessner and D. S. Howell, eds. Marcel Dekker, Inc. New York, p. 435.
4. Mikecz, K., T. T. Glant, E. Buzás, and A. R. Poole. 1990. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum. 33:866.
5. Singer, I. I., D. W. Kawka, E. K. Bayne, S. A. Donatelli, J. R. Weidner, H. A. Williams, R. A. Mumford, M. W. Lark, T. T. Glant, G. H. Nabozny, and C. S. David. 1995. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95:2178.
6. Buzás E., K. Mikecz, F. R. Brennan, and T. T. Glant. 1994. Mediators of autopathogenic effector cells in proteoglycan-induced arthritic and clinically asymptomatic BALB/c mice. Cell. Immunol. 158:292.
7. Mikecz, K., and T. T. Glant. 1994. Migration and homing of lymphocytes to lymphoid and synovial tissues in proteoglycan-induced murine arthritis. Arthritis Rheum. 37:1395.
8. Mikecz, K., F. R. Brennan, J. H. Kim, and T. T. Glant. 1995. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nat. Med. 1:558.
9. Glant, T. T., C. Fülöp, K. Mikecz, E. Buzás, G. Molnár, and P. Erhardt. 1990. Proteoglycan-specific autoreactive antibodies and T-lymphocytes in experimental arthritis and human rheumatoid joint diseases. Biochem. Soc. Trans. 18:796.
10. Fülöp, C., E. Walcz, M. Valyon, and T. T. Glant. 1993. Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species: evidence for a novel module. J. Biol. Chem. 268:17377.
11. Doege, K. J., M. Sasaki, T. Kimura, and Y. Yamada. 1991. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan: human-specific repeats, and additional alternatively spliced forms. J. Biol. Chem. 266:894.
12. Doege, K. J., S. N. Coulter, L. M. Meek, K. Maslen, and J. G. Wood. 1997. A human-specific polymorphism in the coding region of the aggrecan gene: variable number of tandem repeats produce a range of core protein sizes in the general population. J. Biol. Chem. 272:13974.
13. Mai, A., E. Walcz, K. J. Doege, F. Deák, and T. T. Glant. 1994. Expression of cDNA clones encoding core protein sequences of human and mouse aggrecans. Orthop. Trans. 18:375.
14. Roughley, P. J., and R. J. White. 1980. Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J. Biol. Chem. 255:217.
15. Glant, T. T., K. Mikecz, P. J. Roughley, E. Buzás, and A. R. Poole. 1986. Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem. J. 236:71.
16. Dudhia, J., C. M. Davidson, T. M. Wells, D. H. Vynios, T. E. Hardingham, and M. T. Bayliss. 1996. Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage. Biochem. J. 313:933.
17. Buzás, E. I., F. R. Brennan, K. Mikecz, M. Garzó, G. Negroiu, K. Holló, G. Cs-Szabó, É. Pintye, and T. T. Glant. 1995. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J. Immunol. 155:2679.
18. Brennan, F. R., G. Negroiu, E. I. Buzás, C. Fülöp, K. Mikecz, and T. T. Glant. 1995. Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin. Exp. Immunol. 100:104.
19. Brennan, F. R., K. Mikecz, E. I. Buzás, D. Ragasa, G. Cs-Szabó, G. Negroiu, and T. T. Glant. 1995. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin. Exp. Immunol. 101:414.
20. Glant, T. T., K. Mikecz, and A. R. Poole. 1986. Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans. Biochem. J. 234:31.
21. Thonar, E. J. M. A., D. M. Manicourt, J. Williams, M. E. Lenz, M. B. E. Sweet, T. J. Schnitzer, L. Otten, T. Glant, and K. E. Kuettner. 1991. Circulating keratan sulfate: a marker of cartilage proteoglycan metabolism in osteoarthritis. J. Rheumatol. 18:24.
22. Bitter, T., and H. Muir. 1962. A modified uronic-acid-carbazole reaction. Anal. Biochem. 4:320.
23. Lark, M. W., H. Williams, L. A. Hoernner, J. Weidner, J. Ayala, C. F. Harper, A. Christen, J. Olszewski, Z. Konteatis, R. Webber, and R. A. Mumford. 1995. Quantitation of a matrix metalloproteinase-generated aggrecan G1 fragment using a monospecific anti-peptide antiserum. Biochem. J. 307:245.
24. Cs-Szabó, G., P. J. Roughley, A. Plaas, and T. T. Glant. 1995. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum. 38:660.
25. Burrows, S. R., S. J. Rodda, A. Suhrbier, H. M. Geysen, and D. J. Moss. 1992. The specificity of recognition of a cytotoxic T lymphocyte epitope. Eur. J. Immunol. 22:191.
26. Goodacre, J. A., S. Middleton, S. Lynn, D. A. Ross, and J. Pearson. 1993. Human cartilage aggrecan CS1 region contains cryptic T-cell recognition sites. Immunology 78:586.
27. Miltenyi, S., W. Müller, W. Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231.
28. Coffman, R. L., and I. L. Weissman. 1981. B220: a B cell cell-specific member of the T200 glycoprotein family. Nature 289:681.
29. Banerjee, S., and A. R. Poole. 1992. Immunity to cartilage proteoglycans. J. Rheumatol. 19(Suppl. 33):36.
30. Leroux, J.-Y., A. Guerassimov, A. Cartman, N. Delaunay, C. Webber, L. C. Rosenberg, S. Banerjee, and A. R. Poole. 1996. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J. Clin. Invest. 97:621.
31. Goodacre, J. A., and J. P. Pearson. 1992. Human cartilage proteoglycans as T cell autoantigens. Ann. Rheum. Dis. 51:1094.
32. Nakazawa, K., M. Ito, T. Yamagata, and S. Suzuki. 1989. Substrate specificity of keratan sulphate-degrading enzymes (endo-β-galactosidase, keratanase and keratanase II) from microorganisms. In Keratan Sulphate: Chemistry, Biology, Chemical Pathology. H. Greiling and J. E. Scott, eds. The Biochemical Society, London, p. 99.
33. Hascall, V. C., and R. J. Midura. 1989. Keratan sulphate proteoglycans: chemistry and biosynthesis of the linkage regions. In Keratan Sulphate: Chemistry, Biology, Chemical Pathology. H. Greiling and J. E. Scott, eds. The Biochemical Society, London, p. 66.
34. Plaas, A. H. K., F. P. Barry, and S. Wong-Palms. 1992. Keratan sulfate substitution on cartilage matrix molecules. In Articular Cartilage and Osteoarthritis. K. E. Kuettner, R. Schleyerbach, J. G. Peyron, and V. C. Hascall, eds. Raven Press, New York, p. 69.
35. Oegema, T. R., V. C. Hascall, and D. D. Dziewiatkowski. 1975. Isolation and characterization of proteoglycans from the Swarm rat chondrosarcoma. J. Biol. Chem. 250:6151.
36. Kresse, H. 1988. Degradation of keratan sulphate proteoglycans. In Keratan Sulphate: Chemistry, Biology, Chemical Pathology. H. Greiling and J. E. Scott, eds. The Biochemical Society, London, p. 111.
37. Barry, F. P., J. U. Gaw, C. N. Young, and P. J. Neame. 1992. Hyaluronan-binding region of aggrecan from pig laryngeal cartilage: amino acid sequence, analysis of N-linked oligosaccharides and location of the keratan sulphate. Biochem. J. 286: 761.
38. Barry, F. P., P. J. Neame, J. Sasse, and D. Pearson. 1994. Length variation in the keratan sulfate domain of mammalian aggrecan. Matrix Biol. 14:323.
39. Barry, F. P., L. C. Rosenberg, J. U. Gaw, J. U. Gaw, T. J. Koob, and P. J. Neame. 1995. N- and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage. J. Biol. Chem. 270:20516.
40. Poole, A. R., M. Ionescu, A. Swan, and P. A. Dieppe. 1994. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan: implications for pathogenesis. J. Clin. Invest. 94:25.
41. Karopoulos, C., M. J. Rowley, M. Z. Ilic, and C. J. Handley. 1996. Presence of antibodies to native G1 domain of aggrecan core protein in synovial fluids from patients with various joint diseases. Arthritis Rheum. 39:1990.
42. Wooley, P. H., S. W. Siegner, J. D. Whalen, R. I. Karvonen, and F. Fernandez-Madrid. 1992. Dependence of proteoglycan induced arthritis in BALB/c mice on the development of autoantibodies to high density proteoglycans. Ann. Rheum. Dis. 51:983.
43. Poole, A. R., T. T. Glant, and K. Mikecz. 1988. Autoimmunity to cartilage collagen and proteoglycan and the development of chronic inflammatory arthritis. In The Control of Tissue Damage. A. M. Glaurer, ed. Elsevier Publishers (Biomedical Division), Amsterdam, p. 55.
44. Siegel, J. N., G. M. Kammer, and C. J. Malemud. 1987. Intact proteoglycan is a potential activator of murine B-lymphocytes. Immunol. Lett. 15:127.